CVRM (Cardiovasculair Risicomanagement)

(8:)

Our commitment to advancing CVRM treatment

(2:6)

CVRM - Cardio Vasculair Risico Management

(1:2)

CV Impact of Immune Checkpoint Inhibitor Cardiotoxicity

(3:7)

ESC Digital Summit 2019: Healthcare system for cardiovascular risk management-Dr Katrien Groenhof

(6:33)

CVRM in de huisartsenpraktijk

(1:9)

AstraZeneca | Patient Pathways

(1:47)

CVRM en Hart en Vaatziekten - Deel 14a - Perioperatieve antistolling/stelping

(28:25)

AHA PtP Latest Update on CVOT Data for T2DM Therapies Prof Carolyn Lam Su Ping and Prof John McMurry

(11:19)

AHA PtP Cardio Metabolic disease Prof Carolyn Lam Su Ping \u0026 Prof Sobodh Verma

(12:35)

EuroPCR 2019: Renal denervation atrial fibrillation in hypertensive heart disease -Marshall Heradien

(6:16)

AHA 2019: RNA Interference Targeting Apolipoprotein C-III — Dr James Hamilton

(7:22)

EASD 2019: EXSCEL - Dr Lindsay E Clegg

(6:2)

Association Between AID/FID with Incident CV Disease and Mortality | Dr Benedikt Schrage

(2:20)

AHA 2019: Empagliflozin on Erythropoietin Levels – Dr David Mazer

(3:57)

AHA 2019: Updates From The EVAPORATE Study — Prof Matthew Budoff

(3:26)

AHA 2019 : Results Of The BETonMACE Trial — Prof Kausik K Ray

(4:15)

HRS 2019: Baroreflex Activation Therapy - Dr Michael R Zile

(4:44)

Introduction to Cardiovascular Health Concerns Among LGBTQ+ Populations

(29:20)